Hepatic FPR2 expression was significantly higher in healthy females than healthy males (Supplementary Fig. 5), while its level was dramatically reduced in female patients with NAFLD and similar with it in male patients. Here, FPR2 is linked to metabolic dysfunction-associated steatotic liver disease.